PCR-RFLP analysis as an aid to genetic counseling of families of Japanese patients with group A xeroderma pigmentosum

被引:8
作者
Maeda, T [1 ]
Sato, K [1 ]
Minami, H [1 ]
Taguchi, H [1 ]
Yoshikawa, K [1 ]
机构
[1] NAGOYA CITY UNIV,SCH MED,DEPT DERMATOL,NAGOYA,AICHI 467,JAPAN
关键词
XP-A gene; gene frequency;
D O I
10.1111/1523-1747.ep12335796
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Because Japanese patients with complementation group A xeroderma pigmentosum (XP-A) show early skin cancer and severe neurologic dysfunction, their family members are greatly concerned about the risk of inherited disease, In contrast to western XP-A patients, almost all Japanese XP-A patients have two of the three mutations (nonsense mutation in exon 3, splicing mutation in intron 3, and non-sense mutation in exon 6), which are easily detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis, This work was aimed to see whether PCR-RFLP analysis is useful for genetic counseling of XP patients' siblings who are potential carriers of an XP-A gene mutation, In two of the three case studies presented, the probands were homozygous for the splicing mutation in intron 3 of the gene, In their siblings receiving genetic counseling, no mutation was found in the mutation site in one case, and one splicing mutation was found in the second case, In the third case, the proband was a compound heterozygote for the splicing mutation and for an unidentified mutation; in her sibling, no mutation was found in either of these mutation sites, No mutation was found in the siblings' spouses, On the basis of these findings, we reassured the prospective parents that there was little probability of having XP children, but in the second and third cases, we told them that their apparently unaffected children might be carriers, Each couple subsequently had one unaffected child, Thus, PCR-RFLP analysis is useful for genetic counseling of family members of XP-A patients.
引用
收藏
页码:306 / 309
页数:4
相关论文
共 27 条
  • [1] XERODERMA PIGMENTOSUM - BIOCHEMICAL AND GENETIC CHARACTERISTICS
    CLEAVER, JE
    BOOTSMA, D
    [J]. ANNUAL REVIEW OF GENETICS, 1975, 9 : 19 - 38
  • [2] Ikenaga M., 1983, SKIN RES, V25, P222
  • [3] IMAIZUMI Y, 1986, CLIN GENET, V30, P230
  • [4] CORRELATION OF THE CLINICAL MANIFESTATIONS AND GENE-MUTATIONS OF JAPANESE XERODERMA-PIGMENTOSUM GROUP-A PATIENTS
    KONDOH, M
    UEDA, M
    ICHIHASHI, M
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1995, 133 (04) : 579 - 585
  • [5] Kraemer K H, 1985, Clin Dermatol, V3, P33, DOI 10.1016/0738-081X(85)90096-3
  • [6] XERODERMA-PIGMENTOSUM - CUTANEOUS, OCULAR, AND NEUROLOGIC ABNORMALITIES IN 830 PUBLISHED CASES
    KRAEMER, KH
    LEE, MM
    SCOTTO, J
    [J]. ARCHIVES OF DERMATOLOGY, 1987, 123 (02) : 241 - 250
  • [7] LEVITAN M, 1988, TXB HUMAN GENETICS, P219
  • [8] Maeda T, 1995, CLIN GENET, V48, P225
  • [9] MAEDA T, 1994, BRIT J DERMATOL, V131, P566
  • [10] NEUROLOGICAL MANIFESTATIONS IN XERODERMA-PIGMENTOSUM
    MIMAKI, T
    ITOH, N
    ABE, J
    TAGAWA, T
    SATO, K
    YABUUCHI, H
    TAKEBE, H
    [J]. ANNALS OF NEUROLOGY, 1986, 20 (01) : 70 - 75